SCHEDULE: T. Rowe Price Cuts Arvinas Stake to 1.9%
Beneficial Ownership Report
T. Rowe Price Associates, Inc. filed an Amendment No. 2 to Schedule 13G, reporting a reduced 1.9% beneficial ownership stake in Arvinas Inc. common stock.
Summary
- T. Rowe Price Associates, Inc. filed an Amendment No. 2 to Schedule 13G concerning its beneficial ownership in Arvinas Inc.
- The filing reports beneficial ownership of 1,333,977 shares of Arvinas Inc. common stock.
- This represents 1.9% of the total class of securities.
- T. Rowe Price Associates, Inc. holds sole voting power over 1,256,789 shares and sole dispositive power over 1,330,811 shares.
- The event requiring this filing occurred on June 30, 2025, with the statement filed on August 14, 2025.
- T. Rowe Price Associates, Inc. is classified as an investment adviser.
Sentiment
Score: 4
Explanation: The filing is a routine regulatory disclosure of beneficial ownership by an institutional investor. While the continued presence of a major investor is a minor positive, the reduction in stake to 1.9% from a likely higher previous holding (implied by 'Amendment No. 2' and the 13G filing type) suggests a slightly negative sentiment regarding the investor's conviction in the issuer.
Positives
- T. Rowe Price Associates, Inc., a prominent institutional investor, continues to hold a stake in Arvinas Inc., indicating ongoing investment interest.
Negatives
- T. Rowe Price Associates, Inc.'s beneficial ownership in Arvinas Inc. has decreased to 1.9% of the class, as indicated by this Amendment No. 2 to Schedule 13G, suggesting a significant reduction from a previously larger holding.
Future Outlook
NA
Industry Context
This is a routine disclosure by an institutional investor, T. Rowe Price Associates, Inc., regarding its passive ownership stake in Arvinas Inc., a biotechnology company. Such filings are common for large asset managers as they adjust their portfolio holdings, and an amendment indicates a change from a previously reported position.
Stakeholder Impact
- Shareholders: Provides transparency regarding institutional ownership changes, indicating a reduction in T. Rowe Price's stake.
Key Dates
| Date | Description |
|---|---|
| 06/30/2025 | Date of event which requires filing of this statement |
| 08/14/2025 | Date of filing |
Keywords
Arvinas Inc, T. Rowe Price, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.